Three-dimensional structure of a Nanobody® (modeled on the VHH with pdb-code 1U0Q, Cambillau et al). The target molecule is recognized by the surface formed by three hypervariable regions located at the top of the molecule (in green, cyan and blue). Hallmarks, amino acid residues that further differentiate a camelid VHH from a human VH, can be located at different positions within the framework regions, and here are coloured red, pink and magenta.

Home INVESTOR RELATIONS NEWSROOM > PRESS RELEASES

Press Releases

12/12/2008

ABLYNX REPORTS POSITIVE PHASE Ib RESULTS FOR ITS ANTI-THROMBOTIC NANOBODY® ALX-0081

10/12/2008

ABLYNX REACHES MILESTONE IN TNF-alpha NANOBODY® COLLABORATION AS WYETH PHARMACEUTICALS INITIATES PHASE I

08/12/2008

ABLYNX EXPANDS ITS ANTI-THROMBOTIC PORTFOLIO AND ANNOUNCES INITIATION OF A PHASE I STUDYFOR ALX-0681

19/11/2008

ABLYNX PROVIDES A BUSINESS UPDATE FOR THE THIRD QUARTER 2008

05/11/2008

ABLYNX NV - TRANSPARENCY NOTIFICATION

20/10/2008

ABLYNX SECURES NEW FACILITIES TO SUPPORT LONG-TERM GROWTH

10/10/2008

ABLYNX PROVIDES AN R&D UPDATE ANNOUNCING IT HAS SUCCESSFULLY GENERATED NANOBODIES® AGAINST GPCRs AND PRESENTS NEW PRECLINICAL DEVELOPMENT RANKL PROGRAMME

03/10/2008

ABLYNX IS AWARDED €1.8 MILLION GRANT TO EXPLORE NOVEL METHODS FOR USES OF NANOBODIES®

12/09/2008

PUBLICATION IN ACCORDANCE WITH THE ACT OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS

04/09/2008

ABLYNX AND MERCK SERONO ENTER INTO AN AGREEMENT TO CO-DISCOVER AND CO-DEVELOP NANOBODIES®

28/08/2008

ABLYNX ANNOUNCES HALF-YEAR RESULTS FOR 2008

21/08/2008

ABLYNX WILL ANNOUNCE HALF YEAR RESULTS FOR 2008 ON 28 AUGUST 2008

21/08/2008

BOEHRINGER INGELHEIM EXTENDS RESEARCH COLLABORATION WITH ABLYNX FOR ALZHEIMER'S DISEASE

28/05/2008

ABLYNX ANNOUNCES INITIATION OF A PHASE IB STUDY IN PATIENTS FOR ALX-0081 AND PROVIDES A BUSINESS UPDATE FOR THE FIRST QUARTER 2008

27/04/2008

ABLYNX ANNOUNCES SENIOR MANAGEMENT CHANGE

28/02/2008

ABLYNX ANNOUNCES FULL YEAR RESULTS FOR 2007

21/02/2008

ABLYNX WILL ANNOUNCE FULL YEAR RESULTS FOR 2007 ON 28 FEBRUARY 2008

19/02/2008

ABLYNX RECEIVES MILESTONE PAYMENT FROM NANOBODY® DISCOVERY AND DEVELOPMENT ALLIANCE

05/02/2008

ABLYNX RESPONDS TO REQUEST FOR ARBITRATION FROM DOMANTIS

 

Press releases

News archive

Email alerts

If you would like to receive updates on the company news, please
click here